DNA Diagnostic

Fast diagnostic kits for screening of Leukemia-associated translocations


DNA Diagnostic A/S is the manufacturer of HemaVision®, a range of diagnostic kits for screening of translocations associated with Leukemia.

The HemaVision® range can detect up to 28 translocations in just 4 hours, ensuring fast diagnostics and subsequent treatment. HemaVision screens for the most common, as well as rare, translocations and fusion genes.

DNA Diagnostic A/S believes the world deserves fast, cost-effective and reliable diagnostics.

DNA Diagnostic A/S is ISO 13485 certified. HemaVision® products are CE IVD marked and have received a Free Sales Document.

HemaVision® products of DNA Diagnostic

HemaVision®-28Q (HV01-28Q)
HemaVision®-7Q (HV01-7Q)
HemaVision®-28N (HV01-28N)
HemaVision®-Screen (HV01-Screen)
HemaVision®-7 (HV01-7)
HemaVision®-9;22N (HV02-922N)
HemaVision®-8;21N (HV02-821N)
HemaVision®-15;17N (HV02-1517N)
HemaVision®-inv16N (HV02-16N)
HemaVision® -5;12N (HV02-512N)
HemaVision®-1;19 (HV03-119)
HemaVision®-4;11 (HV03-411)
HemaVision®-8;21 (HV03-821)
HemaVision®-9;22 (HV03-922)
HemaVision®-12;21 (HV03-1221)
HemaVision®-15;17 (HV03-1517)
HemaVision®-inv16 (HV03-16)
HemaVision® reagents module* (HV04-RM)
HemaVision®-7 positive controls (HV05-7PC)
HemaVision®-Q positive controls (HV05-PCQ)
HemaVision® reagents module with DNA Polymerase* (HV06-RMP)

Bio-Connect Diagnostics supplies HemaVision® products in the Benelux. If you have any questions, please contact the helpdesk.

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.